Symbol="SPRB"
AssetType="Common Stock"
Name="Spruce BiosciencesÂ Inc"
Description="Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company is headquartered in Daly City, California."
CIK="1683553"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2001 JUNIPERO SERRA BLVD., SUITE 640, DALY CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="84659000"
EBITDA="-48677000"
PERatio="None"
PEGRatio="None"
BookValue="2.717"
DividendPerShare="0"
DividendYield="0"
EPS="-1.84"
RevenuePerShareTTM="0.077"
ProfitMargin="0"
OperatingMarginTTM="-24.82"
ReturnOnAssetsTTM="-0.24"
ReturnOnEquityTTM="-0.453"
RevenueTTM="1964000"
GrossProfitTTM="0"
DilutedEPSTTM="-1.84"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="7.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.315"
EVToRevenue="-"
EVToEBITDA="1.356"
Beta="2.15"
num_52WeekHigh="3.57"
num_52WeekLow="0.955"
num_50DayMovingAverage="2.252"
num_200DayMovingAverage="1.96"
SharesOutstanding="39746100"
DividendDate="None"
ExDividendDate="None"
symbol="SPRB"
open="2.16"
high="2.32"
low="2.13"
price="2.31"
volume="241371.00"
latest_trading_day="2023-07-26"
previous_close="2.13"
change="0.18"
change_percent="8.4507%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="40"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="60"
Volume_recent_avg="138269"
Change_recent_avg="0.01"
Delta_recent_avg="0.13"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.18"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="60"
Aroon_momentum_negative="40"
image_negative_thumbnail_id_1="161"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0015.jpeg"
image_negative_thumbnail_id_2="146"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0030.jpeg"
image_neutral_thumbnail_id_1="574"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_neutral_thumbnail_id_2="563"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_positive_thumbnail_id_1="637"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_positive_thumbnail_id_2="671"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0037.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
